It has recently been shown that the cost of clinical trials may play a crucial role in the drug development process. A lot of the most innovative biotech companies struggled financially last year and many programs have been put on hold or cancelled due to cash flow problems. Many companies have had difficulty finding partners to help them financially to complete even very promising programs. That is why the cost of conducting clinical trials has become one of the major factors for pharma companies’ drug development strategies, their pipelines, and their CRO selection criteria. As market volume shrank CROs had to compete for fewer studies and price has become an important selection criterion.

This presentation provides a comparison of clinical trial costs in central and eastern europe and other representative regions. Our speaker addresses a variety of factors influencing the costs and discusses the dynamics and directions of recent changes. This information is of use in future budget planning, strategic country selection for specific clinical trials and minimizing financial surprises while running trials in CEE.

This audio conference covers:

• Diversification of clinical research market and factors influencing costs
• Examples of CEE costs compared with other representative markets
• Prediction of cost evolution as a result of future clinical research market development in CEE
• Geographic expansion
• Outsourcing model applied by pharma companies

About the speaker:

Dr. Malgorzata Szerszeniewska is CEO of Easthorn Clinical Services, specializing in clinical development in Central and Eastern Europe. Prior to joining Easthorn, she was President of AbCRO, another CEE-focused CRO. There, she was responsible for all operations and strategic development. Dr. Szerszeniewska joined AbCRO after spending over 10 years at Covance where she held various positions including Regional Resource Manager, Project Manager, Director of Strategic Development and Clinical Operations in CEE, and was responsible for development of the company's Clinical Development Services in the region.

Prior to joining Covance she worked as an Anesthesiology and Intensive Care specialist at Warsaw University Hospital. Dr. Szerszeniewska's therapeutic experience includes indications in oncology, anesthesiology, immunology, neurology, gynecology, urology, cardiovascular, psychiatry, ophthalmology, and gastrointestinal medicine. Dr. Szerszeniewska received her Medical Diploma from the Warsaw Medical University.

Who should attend?

• Directors and Managers of Sales
• Project Directors and Managers
• Finance Directors and Managers
• Directors and Managers of Clinical Operations